Hims & Hers Health (HIMS) Cash from Restructuring (2022 - 2026)

Hims & Hers Health has disclosed Cash from Restructuring across 4 years of filings, most recently posting $14.9 million for Q2 2026.

• In Q2 2026, Cash from Restructuring rose 664.4% year-over-year to $14.9 million; the TTM figure through Jun 2026 stood at $24.2 million (up 711.36% YoY), while the FY2025 annual figure was $5.9 million, changed N/A from the prior year.
• Cash from Restructuring came in at $14.9 million for Q2 2026 at Hims & Hers Health, up from $6.4 million in the prior quarter.
• In the past five years, Cash from Restructuring ranged from a high of $14.9 million in Q2 2026 to a low of -$256000.0 in Q3 2022.
• Average Cash from Restructuring over 4 years is $2.2 million, with a median of $981000.0 recorded in 2025.
• The largest YoY upside for Cash from Restructuring was 4645.45% in 2023 against a maximum downside of 58.74% in 2023.
• Over 4 years, Cash from Restructuring stood at $1.0 million in 2022, then sank by 58.74% to $427000.0 in 2023, then surged by 118.27% to $932000.0 in 2025, then jumped by 1503.43% to $14.9 million in 2026.
• Per Business Quant data, the three most recent Cash from Restructuring figures were $14.9 million in Q2 2026, $6.4 million in Q1 2026, and $932000.0 in Q4 2025.